Literature DB >> 9113097

Cytochrome P450 4A and 2E1 expression in human kidney microsomes.

Y Amet1, F Berthou, G Fournier, Y Dréano, L Bardou, J Clèdes, J F Ménez.   

Abstract

Laurate and arachidonate omega and (omega-1)-hydroxylase activities, cytochrome P450 2E1 (CYP2E1), and CYP4A content were measured in 18 human kidney microsomal samples. The rates of laurate and arachidonate were found to be very different from those measured in human liver samples, with a laurate omega/omega-1 ratio of approximately 22 in human kidney vs 0.75 in human liver. Immunoblot analysis of the 18 human kidney microsomal samples identified 1 CYP4A electrophoretic band, but CYP2E1 was not detectable in human kidney, contrary to liver. Laurate and arachidonate omega-hydroxylase activities were significantly correlated with CYP4A content (r = 0.86 and 0.75, respectively). Polyclonal antirat CYP2E1 antibody did not affect omega-hydroxylase activity, whereas the polyclonal antirat CYP4A1 antibody inhibited it by 60%. These results suggest that, in contrast to other species, human kidney microsomes do not contain significant amounts of CYP2E1, but possess CYP4A and fatty acid omega-hydroxylase activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9113097     DOI: 10.1016/s0006-2952(96)00821-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells.

Authors:  Lawrence H Lash; David A Putt; Hongliang Cai
Journal:  Toxicology       Date:  2007-11-04       Impact factor: 4.221

2.  Lack of formic acid production in rat hepatocytes and human renal proximal tubule cells exposed to chloral hydrate or trichloroacetic acid.

Authors:  Edward A Lock; Celia J Reed; Joellyn M McMillan; John E Oatis; Rick G Schnellmann
Journal:  Toxicology       Date:  2006-11-18       Impact factor: 4.221

Review 3.  Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity.

Authors:  Lawrence H Lash; Weihsueh A Chiu; Kathryn Z Guyton; Ivan Rusyn
Journal:  Mutat Res Rev Mutat Res       Date:  2014 Oct-Dec       Impact factor: 5.657

4.  Cytochrome P4502E1 (CYP2E1) expression in peripheral blood lymphocytes: evaluation in hepatitis C and diabetes.

Authors:  Vincent Haufroid; Danuta Ligocka; Martin Buysschaert; Yves Horsmans; Dominique Lison
Journal:  Eur J Clin Pharmacol       Date:  2003-03-22       Impact factor: 2.953

Review 5.  Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).

Authors:  Kathleen M Knights; Andrew Rowland; John O Miners
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

6.  Application of key events analysis to chemical carcinogens and noncarcinogens.

Authors:  Alan R Boobis; George P Daston; R Julian Preston; Stephen S Olin
Journal:  Crit Rev Food Sci Nutr       Date:  2009-09       Impact factor: 11.176

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.